KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Merck (MRK) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $10.5 billion.

  • Merck's Operating Expenses fell 1620.12% to $10.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $42.4 billion, marking a year-over-year decrease of 1422.74%. This contributed to the annual value of $44.2 billion for FY2024, which is 2403.39% down from last year.
  • As of Q3 2025, Merck's Operating Expenses stood at $10.5 billion, which was down 1620.12% from $10.8 billion recorded in Q2 2025.
  • In the past 5 years, Merck's Operating Expenses ranged from a high of $20.4 billion in Q2 2023 and a low of $7.6 billion during Q1 2021
  • For the 5-year period, Merck's Operating Expenses averaged around $11.1 billion, with its median value being $10.3 billion (2023).
  • Its Operating Expenses has fluctuated over the past 5 years, first skyrocketed by 10156.34% in 2023, then crashed by 5038.78% in 2024.
  • Quarter analysis of 5 years shows Merck's Operating Expenses stood at $9.6 billion in 2021, then increased by 7.33% to $10.3 billion in 2022, then skyrocketed by 61.64% to $16.7 billion in 2023, then tumbled by 31.31% to $11.5 billion in 2024, then dropped by 8.06% to $10.5 billion in 2025.
  • Its Operating Expenses stands at $10.5 billion for Q3 2025, versus $10.8 billion for Q2 2025 and $9.6 billion for Q1 2025.